VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness
This study has been completed.
Information provided by:
First received: April 26, 2007
Last updated: October 31, 2007
Last verified: October 2007
The purpose of this study is to determine the safety and efficacy of VSF-173 compared to placebo in treatment of induced excessive sleepiness.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
|Official Title:||A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Investigate the Efficacy and Safety of VSF-173 and Matching Placebo in Healthy Male and Female Subjects With Induced Excessive Sleepiness|
Further study details as provided by Vanda Pharmaceuticals:
Contacts and Locations